SCHEMBL21708892

SCHEMBL21708892

C#CC#CC(=O)NCCc1ccc(O)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.57
HSD17B10 Q99714 3/20 0.57
ALDH1A1 P00352 3/20 0.57
HIF1A Q16665 2/20 0.57
KDM4E B2RXH2 2/20 0.57
LMNA P02545 2/20 0.57
HPGD P15428 2/20 0.57
BLM P54132 2/20 0.57
PTGS1 P23219 1/20 0.57
ALPG P10696 1/20 0.49
APP P05067 1/20 0.49
TRPV1 Q8NER1 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ERCC1 P07992 1/20 0.48
ERCC4 Q92889 1/20 0.48
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708898 0.96 MAPT (0.56) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL109163 0.76 MAPT (0.74) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL7105545 0.76 MAPT (0.74) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL21709273 0.75 MAPT (0.59) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL6420228 0.75 MAPT (0.72) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL15924294 0.74 MAPT (0.61) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL25380895 0.73 MAPT (0.70) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL328568 0.73 MAPT (1.00) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL109158 0.73 MAPT (0.73) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL5500828 0.73 MAPT (0.70) MAPTHSD17B10ALDH1A1HIF1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020032080-A1 COMPOUND, SALT OF COMPOUND, NEUROMODULATION AGENT, METHOD FOR EVALUATING NEUROMODULATION AGENT, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING SALT OF COMPOUND 学校法人慶應義塾 2020-02-13 WO disclosed